MERION, Pa., May 9, 2014 /PRNewswire/ -- The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:

COMPANY

CLASS PERIOD 

The ADT Corporation (NYSE: ADT) 

11/27/12  thru  1/29/14         

Advanced Emissions Solutions Inc. (Nasdaq: ADES) 

3/11/13  thru  3/12/14

CannaVEST Corp.  (OTCQB: CANV)

5/20/13  thru  4/3/14

Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP)


IMPERVA, INC.  (NYSE: IMPV)

5/2/13  thru  4/9/14

Och-Ziff Capital Management Group (NYSE: OZM)

2/9/12  thru  4/25/14

Ruby Tuesday Inc.  (NYSE: RT)

4/11/13  thru  10/9/13

Weight Watchers International, Inc. (NYSE: WTW)

2/14/12  thru  10/30/13

If you purchased securities in any of the companies during the class periods described above and/or own shares in any of the companies and would like to learn more about any potential claims or you wish to discuss these matters and have any questions concerning this announcement or your rights, please contact Marc S. Henzel (610) 660-8000, email at Mhenzel@Henzellaw.com, or to sign up online, visit the firm's website at www.henzellaw.com. 

The Law Offices of Marc S. Henzel is a national shareholder litigation firm representing shareholders & investors in various areas of securities laws including but not limited to; class actions, derivatives, transactional (buyouts/takeovers/mergers) and FINRA & NYSE Arbitrations.

Contact:
Law Offices of Marc S. Henzel
Marc S. Henzel
Email: Mhenzel@Henzellaw.com
Phone 610-660-8000
Website: www.henzellaw.com

LAW OFFICES OF MARC S. HENZEL
431 MONTGOMERY AVE, Suite B
MERION STATION, PA 19066

SOURCE Law Offices of Marc S. Henzel

Copyright 2014 PR Newswire

Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Chelsea Therapeutics International, Ltd. (MM).
Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Chelsea Therapeutics International, Ltd. (MM).